Form 4 Tracker
Sinclair A. Dunlop

Director · 1 filing · Latest: May 14, 2026

Apellis Pharmaceuticals, Inc.
TickerOwnerRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Filing
APLS
Dunlop A. Sinclair—Sep 19, 2025
Proposed Sale
$22.9593,276$2.1M—